DOI: https://doi.org/10.24061/116584

Інтраперитонеальна хіміотерапія раку шлунка (інформаційні матеріали)

R. V. Seniutovych, O. I. Ivashchuk, K. V. Barannikov, V. M. Pylypiv, M. A. Seniutovych, V. Y. Bodiaka, O. V. Chornyi

Анотація


Представлений огляд літератури з проблем інтраперитонеальної хіміотерапії. В усіх дослідженнях відмічено позитивні результати. Перспективним напрямком є інтраперитонеальні ін’єкційні методики із застосування цисплатини, доксорубіцину, паклітакселу.


Ключові слова


рак; шлунок; хіміотерапія інтраперитонеальна; пункційна

Повний текст:

PDF

Посилання


Shchepotin IB, Evans RT. Rak zheludka: prakticheskoe rukovodstvo po profilaktike, diagnostike i lecheniyu [Cancer of the stomach: a practical guide to prevention, diagnosis and treatment]. Kiev: Kniga Plyus; 2000. 277 p. (in Russian).

Yarema RV, Fetsycha TH, Zubareva MH. Rak shlunka z vysokym ryzykom implantatsiinoho metastazuvannia: kliniko-morfolohichni aspekty stratyfikatsii ta suchasni metody likuvannia [Stomach cancer with high risk of implantation metastasis: clinical and morphological aspects of stratification and modern treatments]. Klin. khirurhiia. 2010;5:59-64. (in Ukrainian).

Yarema RV. Intraperytoneal'no dyseminovanyi rak: zakinchennia ery skeptyzmu [Intraperitoneally dismembered cancer: the end of the era of skepticism]. Onkolohiia. 2013;15(2):88-5. (in Ukrainian).

Bae WK, Park MS, Lee JH. Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Biomaterials. 2013;34(4):1433-441.

Bijelic L, Sugarbaker PH. The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastriccancer. Ann. Ital. Chir. 2012;83(3):224-31.

Coccolini F, Lotti M, Manfredi R. Ureteral stenting in cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy as a routine procedure: evidence and necessity. Urol. Int. 2012;89(3):307-10.

Cui SB, Ba M, Tang Y. Ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites. Oncol. Rep. 2012;28(4):1325-331.

Emoto S, Ishigami H, Hidemura A. Complications and management of an implanted intraperitoneal access port system forintraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Jpn. J. Clin. Oncol. 2012;42(11):1013-019.

Emoto S, Yamaguchi H, Kamei T. Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer. Surg. Today. 2013;26:55-8.

Fujiwara. Intrareritoneal docetaxel combined with S-I for advanced gastric cancer with peritoneal dissemination. І. Surg. Oncol. 2012. 105 p.

Fushida S, Kinoshita J, Kaji M. Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol. 2013;71(5):1265-272.

Glehen O, Gilly FN, Arvieux C. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann. Surg. Oncol. 2010;17(9):2370-377.

Glockzin G, Piso P. Current status and future directions in gastric cancer with peritoneal dissemination. Surg. Oncol. Clin. N Am. 2012;21(4):625-33.

Hallaj-Nezhadi S, Dass CR, Lotfipour F. Intraperitoneal delivery of nanoparticles for cancer gene therapy. Future Oncol. 2013;9(1):59-8.

Hasovits C, Clarke S. Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics. Clin. Pharmacokinet. 2012;51(4):203-24.

Huang JY, Xu YY, Sun Z. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac. J. Cancer Prev. 2012;13(9):4379-385.

Hultman B, Lind P, Glimelius B. Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitonealchemotherapy. Acta Oncol. 2013;52(4):824-30.

Imano M, Yasuda A, Itoh T. Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy forgastric cancer with peritoneal metastasis. J. Gastrointest. Surg. 2012;16(12):155-59.

Kanetaka K, Ito S, Susumu S. Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastriccancer. Surgery. 2013;154(3):563-72.

Kang LY, Mok KT, Liu SI. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. J. Chin. Med. Assoc. 2013;76(8):425-31.

Liang H. Intraperitoneal slow released chemotherapy for advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(2):116-17.

Lin Y. Effect of preoperative intraperitoneal injection of Sapylin in advanced gastric cancer. Clin. I. Cancer. 2013;23(4):365-68.

Mi DH, Li Z, Yang KH. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) forgastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int. J. Hyperthermia. 2013;29(2):156-67.

Mizumoto A, Canbay E, Hirano M. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitonealchemotherapy at a single institution in Japan. Gastroenterol. Res. Pract. 2012;18:225-29.

Sun J, Song Y, Wang Z. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion ingastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012;16(12):526.

Wang ZM, Zhuang RY, Chen Y. A pilot study of chemotherapy combined with intraperitoneal perfusion of cytokine-induced killer cells for advanced gastric cancer patients with ascites. Zhonghua Wei Chang Wai Ke Za Zhi. 2013;16(1):28-31.

Xue SL, Su HF, Hu XQ. Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer. Oncol. Lett. 2012;4(6):1309-314.

Yamaguchi H, Kitayama J, Ishigami H. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment ofgastric cancer with macroscopic peritoneal metastasis. Cancer. 2013;119(18):3354-358.

Yonemura Y, Elnemr A, Endou Y. Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer. Int. J. Surg. Oncol. 2012;31:568-72.

Zhao C, Dai C, Chen X. Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer. Int. J. Hyperthermia. 2012;28(8):735-41.


Пристатейна бібліографія ГОСТ






Copyright (c) 2017 R. V. Seniutovych, O. I. Ivashchuk, K. V. Barannikov, V. M. Pylypiv, M. A. Seniutovych, V. Y. Bodiaka, O. V. Chornyi

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2019